Related Experiment Video
Updated: Jun 25, 2026
09:25
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
The multidisciplinary management of osteosarcoma
Noah Federman1, Nicholas Bernthal, Fritz C Eilber
1Division of Pediatric Hematology/Oncology, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Current Treatment Options in Oncology
|February 25, 2009
Summary
Optimal osteosarcoma treatment requires a multidisciplinary team at a comprehensive cancer center, utilizing chemotherapy and limb-preserving surgery. Close follow-up is essential for detecting recurrence and treatment side effects.
Area of Science:
- Oncology
- Orthopedic Surgery
- Cancer Treatment
Background:
- Osteosarcoma is a rare bone cancer requiring specialized care.
- Multidisciplinary approach is crucial for effective management.
Purpose of the Study:
- To outline the essential components of optimal osteosarcoma care.
- To emphasize the importance of specialized centers and clinical trials.
Main Methods:
- Evaluation and treatment at comprehensive cancer centers.
- Multidisciplinary team approach including oncologists, surgeons, pathologists, and radiologists.
- Neoadjuvant and adjuvant multi-agent chemotherapy combined with aggressive, limb-preserving surgery.
Main Results:
- Successful treatment hinges on accurate diagnosis, chemotherapy, and surgical intervention.
- Participation in cooperative group clinical trials is recommended for all patients.
- Long-term surveillance is necessary for recurrence and treatment-related late effects.
Conclusions:
- Despite advances, outcomes for metastatic, recurrent, or refractory osteosarcoma remain challenging.
- A coordinated, multidisciplinary approach offers the best chance for improved patient outcomes.
- Continued research and clinical trials are vital for advancing osteosarcoma treatment.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...